Product
SIRT6-TBS
BIOTECHNOLOGY
byCardivia Labs Inc
United States (US)
ABOUT THE PRODUCT
A Target-Site Blocker (TSB) targeting SIRT6, aimed at promoting vascular rejuvenation and addressing vascular aging.
Information is owner-confirmed
Last updated 2 months ago
Price range